These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8895659)

  • 1. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.
    Mishina Y; Rey R; Finegold MJ; Matzuk MM; Josso N; Cate RL; Behringer RR
    Genes Dev; 1996 Oct; 10(20):2577-87. PubMed ID: 8895659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The müllerian inhibitor and mammalian sexual development.
    Behringer RR
    Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic studies of MIS signalling in sexual development.
    Jamin SP; Arango NA; Mishina Y; Behringer RR
    Novartis Found Symp; 2002; 244():157-64; discussion 164-8, 203-6, 253-7. PubMed ID: 11990789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of inhibins and müllerian-inhibiting substance on testicular tumorigenesis.
    Matzuk MM; Finegold MJ; Mishina Y; Bradley A; Behringer RR
    Mol Endocrinol; 1995 Oct; 9(10):1337-45. PubMed ID: 8544842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.
    Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):15-9. PubMed ID: 14656471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Müllerian-inhibiting substance function during mammalian sexual development.
    Behringer RR; Finegold MJ; Cate RL
    Cell; 1994 Nov; 79(3):415-25. PubMed ID: 7954809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
    Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
    Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
    Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
    Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of Bmpr1a for Müllerian duct regression during male sexual development.
    Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
    Nat Genet; 2002 Nov; 32(3):408-10. PubMed ID: 12368913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a.
    Parr BA; McMahon AP
    Nature; 1998 Oct; 395(6703):707-10. PubMed ID: 9790192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of steroidogenesis in Leydig cells by Müllerian-inhibiting substance.
    Fynn-Thompson E; Cheng H; Teixeira J
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):99-104. PubMed ID: 14656482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
    Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
    Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.
    Wu X; Zhang N; Lee MM
    Endocrinology; 2012 Oct; 153(10):4929-37. PubMed ID: 22872577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.
    Behringer RR; Cate RL; Froelick GJ; Palmiter RD; Brinster RL
    Nature; 1990 May; 345(6271):167-70. PubMed ID: 2336108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
    Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
    Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Müllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained β-catenin signaling.
    Tanwar PS; Commandeur AE; Zhang L; Taketo MM; Teixeira JM
    Carcinogenesis; 2012 Dec; 33(12):2351-61. PubMed ID: 22962306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
    Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
    Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, expression, and regulation of anti-Müllerian hormone type-II receptor in the embryonic chicken gonad.
    Cutting AD; Ayers K; Davidson N; Oshlack A; Doran T; Sinclair AH; Tizard M; Smith CA
    Biol Reprod; 2014 May; 90(5):106. PubMed ID: 24621923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Catenin is essential for Müllerian duct regression during male sexual differentiation.
    Kobayashi A; Stewart CA; Wang Y; Fujioka K; Thomas NC; Jamin SP; Behringer RR
    Development; 2011 May; 138(10):1967-75. PubMed ID: 21490063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.